These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24914056)

  • 21.
    Belloli S; Zanotti L; Murtaj V; Mazzon C; Di Grigoli G; Monterisi C; Masiello V; Iaccarino L; Cappelli A; Poliani PL; Politi LS; Moresco RM
    J Neuroinflammation; 2018 Feb; 15(1):33. PubMed ID: 29402285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis.
    Airas L; Dickens AM; Elo P; Marjamäki P; Johansson J; Eskola O; Jones PA; Trigg W; Solin O; Haaparanta-Solin M; Anthony DC; Rinne J
    J Nucl Med; 2015 Feb; 56(2):305-10. PubMed ID: 25572093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
    Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
    J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
    Castelo-Branco G; Stridh P; Guerreiro-Cacais AO; Adzemovic MZ; Falcão AM; Marta M; Berglund R; Gillett A; Hamza KH; Lassmann H; Hermanson O; Jagodic M
    Neurobiol Dis; 2014 Nov; 71():220-33. PubMed ID: 25149263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.
    Liu H; Jin H; Yue X; Luo Z; Liu C; Rosenberg AJ; Tu Z
    Mol Imaging Biol; 2016 Oct; 18(5):724-32. PubMed ID: 26975859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
    Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
    Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
    Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
    Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
    Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
    J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [11C]PK11195 PET imaging of spinal glial activation after nerve injury in rats.
    Imamoto N; Momosaki S; Fujita M; Omachi S; Yamato H; Kimura M; Kanegawa N; Shinohara S; Abe K
    Neuroimage; 2013 Oct; 79():121-8. PubMed ID: 23611861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis.
    Medina-Fernández FJ; Luque E; Aguilar-Luque M; Agüera E; Feijóo M; García-Maceira FI; Escribano BM; Pascual-Leone Á; Drucker-Colín R; Túnez I
    Life Sci; 2017 Jan; 169():20-26. PubMed ID: 27876534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
    Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM
    Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
    Fjær S; Bø L; Myhr KM; Torkildsen Ø; Wergeland S
    Neurochem Int; 2015; 83-84():28-40. PubMed ID: 25744931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of CNS myelin by positron-emission tomography.
    Stankoff B; Wang Y; Bottlaender M; Aigrot MS; Dolle F; Wu C; Feinstein D; Huang GF; Semah F; Mathis CA; Klunk W; Gould RM; Lubetzki C; Zalc B
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9304-9. PubMed ID: 16754874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
    J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
    Elo P; Li XG; Liljenbäck H; Helin S; Teuho J; Koskensalo K; Saunavaara V; Marjamäki P; Oikonen V; Virta J; Chen Q; Low PS; Knuuti J; Jalkanen S; Airas L; Roivainen A
    J Neuroinflammation; 2019 Dec; 16(1):252. PubMed ID: 31796042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.